MEF2A-mediated HCP5 could exert an anti-tumor effect among the development of GC via miR-106b-5p/p21 axis, which provides a novel target for GC therapy. (33613117)
user: 0
Pubmeds:
Login
For any questions and suggestions, write to us by mail: info@onco.io